BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25146735)

  • 1. Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure.
    Symoens S; Hulmes DJ; Bourhis JM; Coucke PJ; De Paepe A; Malfait F
    Hum Mutat; 2014 Nov; 35(11):1330-41. PubMed ID: 25146735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.
    Pace JM; Kuslich CD; Willing MC; Byers PH
    J Med Genet; 2001 Jul; 38(7):443-9. PubMed ID: 11432962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective C-propeptides of the proalpha2(I) chain of type I procollagen impede molecular assembly and result in osteogenesis imperfecta.
    Pace JM; Wiese M; Drenguis AS; Kuznetsova N; Leikin S; Schwarze U; Chen D; Mooney SH; Unger S; Byers PH
    J Biol Chem; 2008 Jun; 283(23):16061-7. PubMed ID: 18375391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel distinct COL1A2 mutations highlight the complexity of genotype-phenotype correlations in osteogenesis imperfecta and related connective tissue disorders.
    Reuter MS; Schwabe GC; Ehlers C; Marschall C; Reis A; Thiel C; Graul-Neumann L
    Eur J Med Genet; 2013 Dec; 56(12):669-73. PubMed ID: 24140640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
    Pace JM; Chitayat D; Atkinson M; Wilcox WR; Schwarze U; Byers PH
    J Med Genet; 2002 Jan; 39(1):23-9. PubMed ID: 11826020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV.
    Pollitt R; McMahon R; Nunn J; Bamford R; Afifi A; Bishop N; Dalton A
    Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.
    Barnes AM; Ashok A; Makareeva EN; Brusel M; Cabral WA; Weis M; Moali C; Bettler E; Eyre DR; Cassella JP; Leikin S; Hulmes DJS; Kessler E; Marini JC
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2210-2223. PubMed ID: 31055083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
    Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
    Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the COL1A1 and COL1A2 genes associated with osteogenesis imperfecta (OI) types I or III.
    Augusciak-Duma A; Witecka J; Sieron AL; Janeczko M; Pietrzyk JJ; Ochman K; Galicka A; Borszewska-Kornacka MK; Pilch J; Jakubowska-Pietkiewicz E
    Acta Biochim Pol; 2018; 65(1):79-86. PubMed ID: 29543922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and structural characteristics of four novel heterozygous C-propeptide mutations in the proα1(I) collagen gene in Chinese osteogenesis imperfecta patients.
    Lu Y; Ren X; Wang Y; Li T; Li F; Wang S; Xu C; Wu G; Li H; Li G; Zhao F; Wang Z; Mo X; Han J
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):524-31. PubMed ID: 24147872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.
    Malfait F; Symoens S; Goemans N; Gyftodimou Y; Holmberg E; López-González V; Mortier G; Nampoothiri S; Petersen MB; De Paepe A
    Orphanet J Rare Dis; 2013 May; 8():78. PubMed ID: 23692737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mild variant of osteogenesis imperfecta type I caused by a Gly1088Glu mutation in COL1A1.
    Xia XY; Li WW; Li N; Wu QY; Cui YX; Li XJ
    Mol Med Rep; 2014 Jun; 9(6):2187-90. PubMed ID: 24682174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
    Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
    Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
    Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
    Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
    Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
    Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.
    Marini JC; Forlino A; Cabral WA; Barnes AM; San Antonio JD; Milgrom S; Hyland JC; Körkkö J; Prockop DJ; De Paepe A; Coucke P; Symoens S; Glorieux FH; Roughley PJ; Lund AM; Kuurila-Svahn K; Hartikka H; Cohn DH; Krakow D; Mottes M; Schwarze U; Chen D; Yang K; Kuslich C; Troendle J; Dalgleish R; Byers PH
    Hum Mutat; 2007 Mar; 28(3):209-21. PubMed ID: 17078022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a missense mutation of c.3064G>A, Gly1022Ser in exon 43 of COL1A1 gene in a girl with osteogenesis imperfecta type III.
    Chen CP; Lin SP; Suo YN; Chern SR; Su JW; Wang W
    Genet Couns; 2012; 23(3):359-65. PubMed ID: 23072183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
    Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
    J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and assembly of the heterotrimeric and homotrimeric C-propeptides of type I collagen: significance of the alpha2(I) chain.
    Malone JP; Alvares K; Veis A
    Biochemistry; 2005 Nov; 44(46):15269-79. PubMed ID: 16285730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.